Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia

Published:2020-03-31 Issue:2 Volume:191 Page:212-222
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Wang Jia¹^ORCID,Mou Nan²,Yang Zhenxing²,Li Qing¹^ORCID,Jiang Yanyu¹,Meng Juanxia¹,Liu Xuxiang³,Deng Qi¹^ORCID

Affiliation:

1. Department of Hematology Tianjin First Central Hospital Tianjin China

2. Shanghai Genbase Biotechnology Co., Ltd Shanghai China

3. Department of Pathology City of Hope National Medical Center Duarte CA USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16623

Reference33 articles.

1. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

2. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

3. 4-1BB Chimeric Antigen Receptors

4. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

5. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian network analysis of risk classification strategies in the regulation of cellular products;Artificial Intelligence in Medicine;2024-09

2. Advances in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia;Blood Reviews;2024-07

3. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy;Molecular Oncology;2024-03-08

4. ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia;Annals of Oncology;2024-01

5. INSPIRED Symposium Part 2: Prevention and Management of Relapse Following Chimeric Antigen Receptor T Cell Therapy for B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2023-11